CytomX Therapeutics (CTMX) PT Lowered to $8.50 at Citi

September 15, 2020 6:08 AM EDT
Get Alerts CTMX Hot Sheet
Price: $6.70 +0.30%

Rating Summary:
    12 Buy, 3 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 5 | New: 41
Trade Now! 
Join SI Premium – FREE
Citi analyst Mohit Bansal lowered the price target on CytomX Therapeutics (NASDAQ: CTMX) to $8.50 (from $11.00) while maintaining a Neutral rating.

You May Also Be Interested In





Related Categories

Analyst PT Change